Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Devin Pao

Physician Assistant Colorado Springs, CO Physician Assistant

NPI 1770032781 CMS profile 10883710

4110 Briargate Pkwy Ste 300, Colorado Springs, CO 80920

Open in the dashboard

General payments

$7,483

177 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Devin Pao of Colorado Springs, CO is reported in the CMS Open Payments database as having received $7,483 across 177 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,135 54
2024 General $1,293 36
2023 General $2,191 28
2022 General $1,607 51
2021 General $258 8

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Devin Pao
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Devin Pao were reported at $2,135. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Devin Pao Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $258 $132 $37–$438 $132
2022 $1,607 $155 $48–$522 $149
2023 $2,191 $167 $52–$557 $160
2024 $1,293 $178 $55–$600 $164
2025 $2,135 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Stryker Corporation $7,116 160 payments
  2. Avanos Medical $220 11 payments
  3. Vertex Pharmaceuticals Incorporated $54 3 payments
  4. Pacira Pharmaceuticals Incorporated $48 1 payment
  5. OMNIlife science, Inc $25 1 payment
  6. Argentum Medical $21 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $6,931 175 payments
  2. Travel and Lodging $531 1 payment
  3. Entertainment $21 1 payment
Products named General payments · program years 2021–2025
  1. TRIATHLON $2,583 68 payments
  2. ACCOLADE $2,237 54 payments
  3. MAKO $1,722 27 payments
  4. INSIGNIA $695 16 payments
  5. TRIDENT $404 13 payments
  6. ON-Q* PUMP AND ACCESSORIES $180 9 payments
  7. TRITANIUM $170 6 payments
  8. AEQUALIS ASCEND FLEX $120 1 payment
  9. RESTORATION $91 3 payments
  10. JOURNAVX $54 3 payments
  11. Other $182 7 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

540

Median for Physician Assistant: 241

Drug cost

$11,866

Median for Physician Assistant: $4,110

Branded share of claims

3%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Xarelto Rivaroxaban Brand 16 $8,522
Celecoxib Generic 78 $1,560
Meloxicam Generic 165 $523
Oxycodone Hcl Generic 57 $489
Amoxicillin Generic 133 $308
Cyclobenzaprine Hcl Generic 47 $261
Cephalexin Generic 21 $116
Clindamycin Hcl Generic 23 $87

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 27 billing codes

Paid by Medicare

$69,944

Of which drugs: $14,644

Medicare patients

366

Average age 74

Services billed

2,075

244 women, 122 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 67%
Diabetes 24%
Depression 23%
Ischemic heart disease 21%
Chronic kidney disease 17%
Osteoporosis 16%
Atrial fibrillation 13%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, gel-one, for intra-articular injection, per dose J7326 Office 25 35 $13,942
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 94 912 $702

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

177 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record